Register for AMP 2022 to attend sessions sponsored by Illumina.
AMP is the primary resource for expertise, education, and collaboration in the field of molecular pathology. AMP members influence policy and regulation on national and international levels, ultimately serving to advance innovation in the field and protect patient access to high-quality appropriate testing. Join us at AMP to learn how Illumina is enabling genomic breakthroughs in immunotherapy, biomarker discovery, and therapy selection.
Phoenix Convention Center, Room 231AB
Comprehensive genomic profiling (CGP) from liquid biopsy samples
Alison Roos, PhD
Associate Director Medical Affairs
Illumina
Enabling in-house CGP to meet increasingly clinical oncology needs
Wojciech Swat, PhD, DABMGG, FACMG
Director of Cancer Genomics
GenPath Diagnostics
Phoenix Convention Center, Exhibit Hall Floor
Comprehensive genomic testing in patients identification in oncology – Detection of fusions as drivers for therapies
James Solomon, PhD, MD
Medical Director
Clinical Genomics Laboratory at Weill Cornell Medicine